Skip to content

Evaluation of Salvia Officinalis On Radiation-Induced Oral Mucositis

Evaluation of Sage (Salvia Officinalis) leaf hydroalcoholic Extract On Radation-Induced Oral Mucositis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014010410205N2
Enrollment
40
Registered
2014-02-22
Start date
2014-02-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensity of radiation induced oropharyngeal mucositis. Radiation induced mucositis (oropharyngeal)

Interventions

Intervention 1: Herbal extract of plant Salvia officinalis are added to a basic gel to make 2% Sage mouthwash. Patients are instructed to use the mouthwash 3 three times daily from onset of radiothera
Prevention
Placebo
Herbal extract of plant Salvia officinalis are added to a basic gel to make 2% Sage mouthwash. Patients are instructed to use the mouthwash 3 three times daily from onset of radiotherapy for 7 week d
A gel which are equalized in taste, odor, shape and color to 2% Sage mouthwash are used as a placebo mouthwash. Patients are instructed to use the mouthwash 3 three times daily from onset of radiother

Sponsors

Vice chancellor for research and Technology, Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1) Minimum accumulative dose of 40 Gy according to treatment protocol; 2) Complete exposure of oral cavity to radiation field ; 3) Minimum age of 30, maximum 60 Exclusion criteria : 1)Previous history of head and neck radiotherapy ; 2)Intolerance or hypersensitivity to the mouthwash; 3) Preexisting active oral disease; 4) Any systemic diseases interfering with wound healing

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intensity of oral mucositis. Timepoint: Once a week for 7 week. Method of measurement: Oral Mucositis Assessment Scale (OMAS).

Secondary

MeasureTime frame
Hypersesitivity to drug, patient intoerance. Timepoint: Once a week for7 weeks. Method of measurement: History and physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIman Gouran

Babol University of Medical Sciences

imangouran@gmail.com+98 12 3222 0676

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026